Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 156

1.

[Increase in incidence of drug treatments, ethical principles and conflict of interest in cooperation with the pharmaceutical industry].

Hebebrand J, Blanz B, Herpertz-Dahlmann B, Lehmkuhl G.

Z Kinder Jugendpsychiatr Psychother. 2012 May;40(3):133-8. German. No abstract available.

PMID:
22774235
2.
3.
4.

The devil in the detail(ing).

Morreim H.

Am J Bioeth. 2010 Jan;10(1):15-7. doi: 10.1080/15265160903460905. No abstract available.

PMID:
20077328
5.

The details are in the field.

Schwab AP.

Am J Bioeth. 2010 Jan;10(1):19-21. doi: 10.1080/15265160903460921. No abstract available.

PMID:
20077330
6.

Contact with pharmaceutical representatives: where does prudence lead?

Appelbaum PS.

Am J Bioeth. 2010 Jan;10(1):11-3. doi: 10.1080/15265160903441046. No abstract available.

PMID:
20077326
7.

Huddle gets it right, most docs don't.

Rubin PH.

Am J Bioeth. 2010 Jan;10(1):17-9. doi: 10.1080/15265160903441087. No abstract available.

PMID:
20077329
8.

Why academic medical centers should ban drug company gifts to individuals.

Strong C.

Am J Bioeth. 2010 Jan;10(1):13-5. doi: 10.1080/15265160903441061. No abstract available.

PMID:
20077327
9.

Drug detailers, professionalism, and prudence.

Brody H.

Am J Bioeth. 2010 Jan;10(1):9-10. doi: 10.1080/15265160903441020. No abstract available.

PMID:
20077325
10.

Marketing of antipsychotic drugs targeted doctors of Medicaid patients, report says.

Roehr B.

BMJ. 2012 Oct 2;345:e6633. doi: 10.1136/bmj.e6633. No abstract available.

PMID:
23033376
11.

Avoiding over-deterrence in managing physicians' relationships with industry.

Stell LK.

Am J Bioeth. 2010 Jan;10(1):27-9. doi: 10.1080/15265160903441129. No abstract available.

PMID:
20077334
12.

The AAMC exhibits the behavior it condemns.

Stossel TP.

Am J Bioeth. 2010 Jan;10(1):26-7. doi: 10.1080/15265160903441095. No abstract available.

PMID:
20077333
13.

The pitfalls of misreading: what does "industry funding of medical education" actually say?

Spielman B.

Am J Bioeth. 2010 Jan;10(1):24-5. doi: 10.1080/15265160903441038. No abstract available.

PMID:
20077332
14.

Doctors and the drug industry: reader feedback.

Warrier R, Houghton B.

Am J Med. 2005 Oct;118(10):1175-6; author reply 1176. No abstract available.

PMID:
16194656
15.

Medicine and the pharmaceutical industry: a call to action.

Stiles MM, Barrett B.

Am Fam Physician. 2007 May 15;75(10):1447, 1451; discussion 1451. No abstract available.

16.

Doctors and the drug industry: reader feedback.

Nardone DA.

Am J Med. 2005 Oct;118(10):1176-7; author reply 1177. No abstract available.

PMID:
16194658
17.
18.

Should physicians rely on pharmaceutical detailing for their education?

van Schalkwyk JM, Turner MJ.

J Clin Hypertens (Greenwich). 2013 Mar;15(3):218. doi: 10.1111/jch.12044. Epub 2012 Dec 14. No abstract available.

19.

Financial incentives and the prescription of newer vaccines by doctors in India.

Lodha R, Bhargava A.

Indian J Med Ethics. 2010 Jan-Mar;7(1):28-30. No abstract available.

PMID:
20166294
20.

Getting drug money out of doctors' offices....

Nagarkar PA.

Pharos Alpha Omega Alpha Honor Med Soc. 2010 Winter;73(1):13-7. No abstract available.

PMID:
20178201

Supplemental Content

Support Center